Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)

Conditions:   Hyperactivity in Children With Down Syndrome;   Impulsivity in Children With Down Syndrome Interventions:   Drug: Guanfacine Hydrochloride Immediate Release;   Drug: Placebo Sponsors:   Rachel G. Greenberg, MD, MB, MHS;   The Emmes Company, LLC;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials